nodes	percent_of_prediction	percent_of_DWPC	metapath
Acitretin—ALB—liver cancer	0.411	1	CbGaD
Acitretin—Alitretinoin—CRABP1—liver cancer	0.0062	0.513	CrCbGaD
Acitretin—CYP26A1—embryo—liver cancer	0.00599	0.264	CbGeAlD
Acitretin—Tretinoin—CRABP1—liver cancer	0.00437	0.362	CrCbGaD
Acitretin—RBP1—embryo—liver cancer	0.00358	0.157	CbGeAlD
Acitretin—CYP26A1—liver—liver cancer	0.00277	0.122	CbGeAlD
Acitretin—ALB—gall bladder—liver cancer	0.00226	0.0993	CbGeAlD
Acitretin—RXRA—liver—liver cancer	0.0017	0.075	CbGeAlD
Acitretin—RBP1—liver—liver cancer	0.00165	0.0728	CbGeAlD
Acitretin—RARB—liver—liver cancer	0.00153	0.0673	CbGeAlD
Acitretin—RXRB—liver—liver cancer	0.00141	0.0619	CbGeAlD
Acitretin—RARA—liver—liver cancer	0.00117	0.0516	CbGeAlD
Acitretin—Vitamin A—CYP1A1—liver cancer	0.000769	0.0636	CrCbGaD
Acitretin—Tretinoin—CYP1A1—liver cancer	0.000743	0.0615	CrCbGaD
Acitretin—ALB—liver—liver cancer	0.000662	0.0291	CbGeAlD
Acitretin—Bone disorder—Doxorubicin—liver cancer	0.000624	0.00275	CcSEcCtD
Acitretin—Blood uric acid increased—Epirubicin—liver cancer	0.00062	0.00273	CcSEcCtD
Acitretin—Arthropathy—Doxorubicin—liver cancer	0.00062	0.00273	CcSEcCtD
Acitretin—Myalgia—Sorafenib—liver cancer	0.000613	0.0027	CcSEcCtD
Acitretin—Arthralgia—Sorafenib—liver cancer	0.000613	0.0027	CcSEcCtD
Acitretin—Herpes simplex—Doxorubicin—liver cancer	0.000612	0.0027	CcSEcCtD
Acitretin—Glossitis—Doxorubicin—liver cancer	0.000612	0.0027	CcSEcCtD
Acitretin—Dry mouth—Sorafenib—liver cancer	0.0006	0.00264	CcSEcCtD
Acitretin—Melaena—Epirubicin—liver cancer	0.000595	0.00262	CcSEcCtD
Acitretin—Creatinine increased—Doxorubicin—liver cancer	0.000592	0.00261	CcSEcCtD
Acitretin—Influenza like illness—Epirubicin—liver cancer	0.000592	0.00261	CcSEcCtD
Acitretin—Salivary hypersecretion—Epirubicin—liver cancer	0.000592	0.00261	CcSEcCtD
Acitretin—Bone pain—Doxorubicin—liver cancer	0.000588	0.00259	CcSEcCtD
Acitretin—Infection—Sorafenib—liver cancer	0.000584	0.00258	CcSEcCtD
Acitretin—Candida infection—Epirubicin—liver cancer	0.000582	0.00256	CcSEcCtD
Acitretin—Skin exfoliation—Epirubicin—liver cancer	0.000582	0.00256	CcSEcCtD
Acitretin—Gait disturbance—Doxorubicin—liver cancer	0.000577	0.00255	CcSEcCtD
Acitretin—Blood uric acid increased—Doxorubicin—liver cancer	0.000574	0.00253	CcSEcCtD
Acitretin—Skin disorder—Sorafenib—liver cancer	0.000571	0.00252	CcSEcCtD
Acitretin—Dry eye—Epirubicin—liver cancer	0.000563	0.00248	CcSEcCtD
Acitretin—Anorexia—Sorafenib—liver cancer	0.000561	0.00247	CcSEcCtD
Acitretin—Cramps of lower extremities—Epirubicin—liver cancer	0.00056	0.00247	CcSEcCtD
Acitretin—Oesophagitis—Epirubicin—liver cancer	0.000557	0.00245	CcSEcCtD
Acitretin—Mouth ulceration—Epirubicin—liver cancer	0.000551	0.00243	CcSEcCtD
Acitretin—Melaena—Doxorubicin—liver cancer	0.000551	0.00243	CcSEcCtD
Acitretin—Salivary hypersecretion—Doxorubicin—liver cancer	0.000547	0.00241	CcSEcCtD
Acitretin—Influenza like illness—Doxorubicin—liver cancer	0.000547	0.00241	CcSEcCtD
Acitretin—Skin exfoliation—Doxorubicin—liver cancer	0.000538	0.00237	CcSEcCtD
Acitretin—Candida infection—Doxorubicin—liver cancer	0.000538	0.00237	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000536	0.00236	CcSEcCtD
Acitretin—Hypertonia—Epirubicin—liver cancer	0.000534	0.00235	CcSEcCtD
Acitretin—Dry eye—Doxorubicin—liver cancer	0.000521	0.00229	CcSEcCtD
Acitretin—Cramps of lower extremities—Doxorubicin—liver cancer	0.000518	0.00228	CcSEcCtD
Acitretin—Dyspepsia—Sorafenib—liver cancer	0.000518	0.00228	CcSEcCtD
Acitretin—Oesophagitis—Doxorubicin—liver cancer	0.000515	0.00227	CcSEcCtD
Acitretin—Decreased appetite—Sorafenib—liver cancer	0.000511	0.00225	CcSEcCtD
Acitretin—Mouth ulceration—Doxorubicin—liver cancer	0.00051	0.00225	CcSEcCtD
Acitretin—Diabetes mellitus—Epirubicin—liver cancer	0.000508	0.00224	CcSEcCtD
Acitretin—Gastrointestinal disorder—Sorafenib—liver cancer	0.000508	0.00224	CcSEcCtD
Acitretin—Fatigue—Sorafenib—liver cancer	0.000507	0.00223	CcSEcCtD
Acitretin—Hepatic function abnormal—Epirubicin—liver cancer	0.000506	0.00223	CcSEcCtD
Acitretin—Photosensitivity—Epirubicin—liver cancer	0.000504	0.00222	CcSEcCtD
Acitretin—Pain—Sorafenib—liver cancer	0.000503	0.00222	CcSEcCtD
Acitretin—Constipation—Sorafenib—liver cancer	0.000503	0.00222	CcSEcCtD
Acitretin—Vascular purpura—Epirubicin—liver cancer	0.000494	0.00218	CcSEcCtD
Acitretin—Hypertonia—Doxorubicin—liver cancer	0.000494	0.00218	CcSEcCtD
Acitretin—Eczema—Epirubicin—liver cancer	0.000492	0.00217	CcSEcCtD
Acitretin—Eye pain—Epirubicin—liver cancer	0.00049	0.00216	CcSEcCtD
Acitretin—Gastrointestinal pain—Sorafenib—liver cancer	0.000481	0.00212	CcSEcCtD
Acitretin—Hot flush—Epirubicin—liver cancer	0.000473	0.00208	CcSEcCtD
Acitretin—Increased appetite—Epirubicin—liver cancer	0.000471	0.00207	CcSEcCtD
Acitretin—Diabetes mellitus—Doxorubicin—liver cancer	0.00047	0.00207	CcSEcCtD
Acitretin—Menopausal symptoms—Epirubicin—liver cancer	0.000469	0.00207	CcSEcCtD
Acitretin—Dermatitis exfoliative—Epirubicin—liver cancer	0.000469	0.00207	CcSEcCtD
Acitretin—Hepatic function abnormal—Doxorubicin—liver cancer	0.000468	0.00206	CcSEcCtD
Acitretin—Urticaria—Sorafenib—liver cancer	0.000467	0.00206	CcSEcCtD
Acitretin—Photosensitivity—Doxorubicin—liver cancer	0.000466	0.00205	CcSEcCtD
Acitretin—Abdominal pain—Sorafenib—liver cancer	0.000465	0.00205	CcSEcCtD
Acitretin—Body temperature increased—Sorafenib—liver cancer	0.000465	0.00205	CcSEcCtD
Acitretin—Dermatitis bullous—Epirubicin—liver cancer	0.000463	0.00204	CcSEcCtD
Acitretin—Purpura—Epirubicin—liver cancer	0.000459	0.00202	CcSEcCtD
Acitretin—Vascular purpura—Doxorubicin—liver cancer	0.000457	0.00202	CcSEcCtD
Acitretin—Eczema—Doxorubicin—liver cancer	0.000455	0.00201	CcSEcCtD
Acitretin—Eye pain—Doxorubicin—liver cancer	0.000453	0.002	CcSEcCtD
Acitretin—Cerebrovascular accident—Epirubicin—liver cancer	0.000451	0.00199	CcSEcCtD
Acitretin—Diplopia—Epirubicin—liver cancer	0.000442	0.00195	CcSEcCtD
Acitretin—Osteoarthritis—Epirubicin—liver cancer	0.000442	0.00195	CcSEcCtD
Acitretin—Hot flush—Doxorubicin—liver cancer	0.000437	0.00193	CcSEcCtD
Acitretin—Increased appetite—Doxorubicin—liver cancer	0.000435	0.00192	CcSEcCtD
Acitretin—Migraine—Epirubicin—liver cancer	0.000435	0.00192	CcSEcCtD
Acitretin—Menopausal symptoms—Doxorubicin—liver cancer	0.000434	0.00191	CcSEcCtD
Acitretin—Dermatitis exfoliative—Doxorubicin—liver cancer	0.000434	0.00191	CcSEcCtD
Acitretin—Hypersensitivity—Sorafenib—liver cancer	0.000433	0.00191	CcSEcCtD
Acitretin—Dermatitis bullous—Doxorubicin—liver cancer	0.000428	0.00189	CcSEcCtD
Acitretin—Purpura—Doxorubicin—liver cancer	0.000424	0.00187	CcSEcCtD
Acitretin—Asthenia—Sorafenib—liver cancer	0.000422	0.00186	CcSEcCtD
Acitretin—Cerebrovascular accident—Doxorubicin—liver cancer	0.000417	0.00184	CcSEcCtD
Acitretin—Pruritus—Sorafenib—liver cancer	0.000416	0.00183	CcSEcCtD
Acitretin—Blood creatinine increased—Epirubicin—liver cancer	0.000414	0.00183	CcSEcCtD
Acitretin—Diplopia—Doxorubicin—liver cancer	0.000409	0.0018	CcSEcCtD
Acitretin—Osteoarthritis—Doxorubicin—liver cancer	0.000409	0.0018	CcSEcCtD
Acitretin—Liver function test abnormal—Epirubicin—liver cancer	0.000408	0.0018	CcSEcCtD
Acitretin—Dry skin—Epirubicin—liver cancer	0.000405	0.00179	CcSEcCtD
Acitretin—Migraine—Doxorubicin—liver cancer	0.000403	0.00178	CcSEcCtD
Acitretin—Diarrhoea—Sorafenib—liver cancer	0.000402	0.00177	CcSEcCtD
Acitretin—Gastritis—Epirubicin—liver cancer	0.000391	0.00172	CcSEcCtD
Acitretin—Muscular weakness—Epirubicin—liver cancer	0.00039	0.00172	CcSEcCtD
Acitretin—Alanine aminotransferase increased—Epirubicin—liver cancer	0.00039	0.00172	CcSEcCtD
Acitretin—Dizziness—Sorafenib—liver cancer	0.000389	0.00171	CcSEcCtD
Acitretin—Blood creatinine increased—Doxorubicin—liver cancer	0.000383	0.00169	CcSEcCtD
Acitretin—Liver function test abnormal—Doxorubicin—liver cancer	0.000378	0.00167	CcSEcCtD
Acitretin—Dry skin—Doxorubicin—liver cancer	0.000375	0.00165	CcSEcCtD
Acitretin—Pancreatitis—Epirubicin—liver cancer	0.000375	0.00165	CcSEcCtD
Acitretin—Vomiting—Sorafenib—liver cancer	0.000374	0.00165	CcSEcCtD
Acitretin—Rash—Sorafenib—liver cancer	0.000371	0.00163	CcSEcCtD
Acitretin—Dermatitis—Sorafenib—liver cancer	0.00037	0.00163	CcSEcCtD
Acitretin—Headache—Sorafenib—liver cancer	0.000368	0.00162	CcSEcCtD
Acitretin—Pancytopenia—Epirubicin—liver cancer	0.000363	0.0016	CcSEcCtD
Acitretin—Gastritis—Doxorubicin—liver cancer	0.000362	0.0016	CcSEcCtD
Acitretin—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000361	0.00159	CcSEcCtD
Acitretin—Muscular weakness—Doxorubicin—liver cancer	0.000361	0.00159	CcSEcCtD
Acitretin—Dysuria—Epirubicin—liver cancer	0.000357	0.00158	CcSEcCtD
Acitretin—Nausea—Sorafenib—liver cancer	0.000349	0.00154	CcSEcCtD
Acitretin—Photosensitivity reaction—Epirubicin—liver cancer	0.000349	0.00154	CcSEcCtD
Acitretin—Weight increased—Epirubicin—liver cancer	0.000348	0.00153	CcSEcCtD
Acitretin—Pancreatitis—Doxorubicin—liver cancer	0.000347	0.00153	CcSEcCtD
Acitretin—Weight decreased—Epirubicin—liver cancer	0.000346	0.00152	CcSEcCtD
Acitretin—Pancytopenia—Doxorubicin—liver cancer	0.000336	0.00148	CcSEcCtD
Acitretin—Neuropathy peripheral—Epirubicin—liver cancer	0.000334	0.00147	CcSEcCtD
Acitretin—Jaundice—Epirubicin—liver cancer	0.000332	0.00146	CcSEcCtD
Acitretin—Stomatitis—Epirubicin—liver cancer	0.000332	0.00146	CcSEcCtD
Acitretin—Urinary tract infection—Epirubicin—liver cancer	0.000331	0.00146	CcSEcCtD
Acitretin—Conjunctivitis—Epirubicin—liver cancer	0.000331	0.00146	CcSEcCtD
Acitretin—Dysuria—Doxorubicin—liver cancer	0.000331	0.00146	CcSEcCtD
Acitretin—Haematuria—Epirubicin—liver cancer	0.000325	0.00143	CcSEcCtD
Acitretin—Photosensitivity reaction—Doxorubicin—liver cancer	0.000323	0.00142	CcSEcCtD
Acitretin—Weight increased—Doxorubicin—liver cancer	0.000322	0.00142	CcSEcCtD
Acitretin—Epistaxis—Epirubicin—liver cancer	0.000321	0.00142	CcSEcCtD
Acitretin—Weight decreased—Doxorubicin—liver cancer	0.00032	0.00141	CcSEcCtD
Acitretin—Sinusitis—Epirubicin—liver cancer	0.00032	0.00141	CcSEcCtD
Acitretin—Neuropathy peripheral—Doxorubicin—liver cancer	0.000309	0.00136	CcSEcCtD
Acitretin—Haemoglobin—Epirubicin—liver cancer	0.000307	0.00136	CcSEcCtD
Acitretin—Stomatitis—Doxorubicin—liver cancer	0.000307	0.00135	CcSEcCtD
Acitretin—Jaundice—Doxorubicin—liver cancer	0.000307	0.00135	CcSEcCtD
Acitretin—Rhinitis—Epirubicin—liver cancer	0.000307	0.00135	CcSEcCtD
Acitretin—Conjunctivitis—Doxorubicin—liver cancer	0.000306	0.00135	CcSEcCtD
Acitretin—Urinary tract infection—Doxorubicin—liver cancer	0.000306	0.00135	CcSEcCtD
Acitretin—Haemorrhage—Epirubicin—liver cancer	0.000306	0.00135	CcSEcCtD
Acitretin—Hepatitis—Epirubicin—liver cancer	0.000306	0.00135	CcSEcCtD
Acitretin—Hypoaesthesia—Epirubicin—liver cancer	0.000304	0.00134	CcSEcCtD
Acitretin—Pharyngitis—Epirubicin—liver cancer	0.000304	0.00134	CcSEcCtD
Acitretin—Oedema peripheral—Epirubicin—liver cancer	0.000301	0.00133	CcSEcCtD
Acitretin—Haematuria—Doxorubicin—liver cancer	0.000301	0.00133	CcSEcCtD
Acitretin—Epistaxis—Doxorubicin—liver cancer	0.000297	0.00131	CcSEcCtD
Acitretin—Sinusitis—Doxorubicin—liver cancer	0.000296	0.0013	CcSEcCtD
Acitretin—Visual impairment—Epirubicin—liver cancer	0.000295	0.0013	CcSEcCtD
Acitretin—Eye disorder—Epirubicin—liver cancer	0.000286	0.00126	CcSEcCtD
Acitretin—Tinnitus—Epirubicin—liver cancer	0.000285	0.00126	CcSEcCtD
Acitretin—Haemoglobin—Doxorubicin—liver cancer	0.000284	0.00125	CcSEcCtD
Acitretin—Flushing—Epirubicin—liver cancer	0.000284	0.00125	CcSEcCtD
Acitretin—Rhinitis—Doxorubicin—liver cancer	0.000284	0.00125	CcSEcCtD
Acitretin—Haemorrhage—Doxorubicin—liver cancer	0.000283	0.00125	CcSEcCtD
Acitretin—Hepatitis—Doxorubicin—liver cancer	0.000283	0.00125	CcSEcCtD
Acitretin—Hypoaesthesia—Doxorubicin—liver cancer	0.000282	0.00124	CcSEcCtD
Acitretin—Pharyngitis—Doxorubicin—liver cancer	0.000281	0.00124	CcSEcCtD
Acitretin—Oedema peripheral—Doxorubicin—liver cancer	0.000279	0.00123	CcSEcCtD
Acitretin—Angiopathy—Epirubicin—liver cancer	0.000278	0.00122	CcSEcCtD
Acitretin—Immune system disorder—Epirubicin—liver cancer	0.000276	0.00122	CcSEcCtD
Acitretin—Chills—Epirubicin—liver cancer	0.000274	0.00121	CcSEcCtD
Acitretin—Visual impairment—Doxorubicin—liver cancer	0.000273	0.0012	CcSEcCtD
Acitretin—Alopecia—Epirubicin—liver cancer	0.00027	0.00119	CcSEcCtD
Acitretin—Erythema—Epirubicin—liver cancer	0.000266	0.00117	CcSEcCtD
Acitretin—Eye disorder—Doxorubicin—liver cancer	0.000264	0.00117	CcSEcCtD
Acitretin—Tinnitus—Doxorubicin—liver cancer	0.000264	0.00116	CcSEcCtD
Acitretin—Flushing—Doxorubicin—liver cancer	0.000263	0.00116	CcSEcCtD
Acitretin—Tension—Epirubicin—liver cancer	0.000261	0.00115	CcSEcCtD
Acitretin—Dysgeusia—Epirubicin—liver cancer	0.000261	0.00115	CcSEcCtD
Acitretin—Nervousness—Epirubicin—liver cancer	0.000259	0.00114	CcSEcCtD
Acitretin—Back pain—Epirubicin—liver cancer	0.000258	0.00114	CcSEcCtD
Acitretin—Angiopathy—Doxorubicin—liver cancer	0.000257	0.00113	CcSEcCtD
Acitretin—Muscle spasms—Epirubicin—liver cancer	0.000256	0.00113	CcSEcCtD
Acitretin—Immune system disorder—Doxorubicin—liver cancer	0.000256	0.00113	CcSEcCtD
Acitretin—Chills—Doxorubicin—liver cancer	0.000254	0.00112	CcSEcCtD
Acitretin—Vision blurred—Epirubicin—liver cancer	0.000251	0.00111	CcSEcCtD
Acitretin—Alopecia—Doxorubicin—liver cancer	0.00025	0.0011	CcSEcCtD
Acitretin—Ill-defined disorder—Epirubicin—liver cancer	0.000247	0.00109	CcSEcCtD
Acitretin—Erythema—Doxorubicin—liver cancer	0.000246	0.00109	CcSEcCtD
Acitretin—Tension—Doxorubicin—liver cancer	0.000242	0.00107	CcSEcCtD
Acitretin—Dysgeusia—Doxorubicin—liver cancer	0.000241	0.00106	CcSEcCtD
Acitretin—Malaise—Epirubicin—liver cancer	0.00024	0.00106	CcSEcCtD
Acitretin—Nervousness—Doxorubicin—liver cancer	0.000239	0.00105	CcSEcCtD
Acitretin—Back pain—Doxorubicin—liver cancer	0.000238	0.00105	CcSEcCtD
Acitretin—Muscle spasms—Doxorubicin—liver cancer	0.000237	0.00104	CcSEcCtD
Acitretin—Cough—Epirubicin—liver cancer	0.000232	0.00102	CcSEcCtD
Acitretin—Vision blurred—Doxorubicin—liver cancer	0.000232	0.00102	CcSEcCtD
Acitretin—Ill-defined disorder—Doxorubicin—liver cancer	0.000229	0.00101	CcSEcCtD
Acitretin—Myalgia—Epirubicin—liver cancer	0.000227	0.000999	CcSEcCtD
Acitretin—Chest pain—Epirubicin—liver cancer	0.000227	0.000999	CcSEcCtD
Acitretin—Arthralgia—Epirubicin—liver cancer	0.000227	0.000999	CcSEcCtD
Acitretin—Anxiety—Epirubicin—liver cancer	0.000226	0.000996	CcSEcCtD
Acitretin—Discomfort—Epirubicin—liver cancer	0.000224	0.000987	CcSEcCtD
Acitretin—Malaise—Doxorubicin—liver cancer	0.000222	0.000979	CcSEcCtD
Acitretin—Dry mouth—Epirubicin—liver cancer	0.000222	0.000977	CcSEcCtD
Acitretin—Oedema—Epirubicin—liver cancer	0.000217	0.000958	CcSEcCtD
Acitretin—Infection—Epirubicin—liver cancer	0.000216	0.000952	CcSEcCtD
Acitretin—Cough—Doxorubicin—liver cancer	0.000215	0.000948	CcSEcCtD
Acitretin—Skin disorder—Epirubicin—liver cancer	0.000211	0.000931	CcSEcCtD
Acitretin—Hyperhidrosis—Epirubicin—liver cancer	0.00021	0.000926	CcSEcCtD
Acitretin—Arthralgia—Doxorubicin—liver cancer	0.00021	0.000925	CcSEcCtD
Acitretin—Chest pain—Doxorubicin—liver cancer	0.00021	0.000925	CcSEcCtD
Acitretin—Myalgia—Doxorubicin—liver cancer	0.00021	0.000925	CcSEcCtD
Acitretin—Anxiety—Doxorubicin—liver cancer	0.000209	0.000921	CcSEcCtD
Acitretin—Discomfort—Doxorubicin—liver cancer	0.000207	0.000914	CcSEcCtD
Acitretin—Anorexia—Epirubicin—liver cancer	0.000207	0.000913	CcSEcCtD
Acitretin—Dry mouth—Doxorubicin—liver cancer	0.000205	0.000904	CcSEcCtD
Acitretin—Oedema—Doxorubicin—liver cancer	0.000201	0.000886	CcSEcCtD
Acitretin—Infection—Doxorubicin—liver cancer	0.0002	0.000881	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000198	0.000873	CcSEcCtD
Acitretin—Insomnia—Epirubicin—liver cancer	0.000197	0.000866	CcSEcCtD
Acitretin—Skin disorder—Doxorubicin—liver cancer	0.000195	0.000861	CcSEcCtD
Acitretin—Paraesthesia—Epirubicin—liver cancer	0.000195	0.00086	CcSEcCtD
Acitretin—Hyperhidrosis—Doxorubicin—liver cancer	0.000194	0.000857	CcSEcCtD
Acitretin—Somnolence—Epirubicin—liver cancer	0.000193	0.000852	CcSEcCtD
Acitretin—Anorexia—Doxorubicin—liver cancer	0.000192	0.000845	CcSEcCtD
Acitretin—Dyspepsia—Epirubicin—liver cancer	0.000191	0.000843	CcSEcCtD
Acitretin—Decreased appetite—Epirubicin—liver cancer	0.000189	0.000833	CcSEcCtD
Acitretin—Gastrointestinal disorder—Epirubicin—liver cancer	0.000188	0.000827	CcSEcCtD
Acitretin—Fatigue—Epirubicin—liver cancer	0.000187	0.000826	CcSEcCtD
Acitretin—Pain—Epirubicin—liver cancer	0.000186	0.000819	CcSEcCtD
Acitretin—Constipation—Epirubicin—liver cancer	0.000186	0.000819	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000183	0.000808	CcSEcCtD
Acitretin—Insomnia—Doxorubicin—liver cancer	0.000182	0.000802	CcSEcCtD
Acitretin—Paraesthesia—Doxorubicin—liver cancer	0.000181	0.000796	CcSEcCtD
Acitretin—Feeling abnormal—Epirubicin—liver cancer	0.000179	0.000789	CcSEcCtD
Acitretin—Somnolence—Doxorubicin—liver cancer	0.000179	0.000788	CcSEcCtD
Acitretin—Gastrointestinal pain—Epirubicin—liver cancer	0.000178	0.000783	CcSEcCtD
Acitretin—Dyspepsia—Doxorubicin—liver cancer	0.000177	0.00078	CcSEcCtD
Acitretin—Decreased appetite—Doxorubicin—liver cancer	0.000175	0.000771	CcSEcCtD
Acitretin—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000174	0.000765	CcSEcCtD
Acitretin—Fatigue—Doxorubicin—liver cancer	0.000173	0.000764	CcSEcCtD
Acitretin—Urticaria—Epirubicin—liver cancer	0.000173	0.000761	CcSEcCtD
Acitretin—Pain—Doxorubicin—liver cancer	0.000172	0.000758	CcSEcCtD
Acitretin—Constipation—Doxorubicin—liver cancer	0.000172	0.000758	CcSEcCtD
Acitretin—Body temperature increased—Epirubicin—liver cancer	0.000172	0.000757	CcSEcCtD
Acitretin—Abdominal pain—Epirubicin—liver cancer	0.000172	0.000757	CcSEcCtD
Acitretin—Feeling abnormal—Doxorubicin—liver cancer	0.000166	0.00073	CcSEcCtD
Acitretin—Gastrointestinal pain—Doxorubicin—liver cancer	0.000164	0.000725	CcSEcCtD
Acitretin—Hypersensitivity—Epirubicin—liver cancer	0.00016	0.000706	CcSEcCtD
Acitretin—Urticaria—Doxorubicin—liver cancer	0.00016	0.000704	CcSEcCtD
Acitretin—Abdominal pain—Doxorubicin—liver cancer	0.000159	0.000701	CcSEcCtD
Acitretin—Body temperature increased—Doxorubicin—liver cancer	0.000159	0.000701	CcSEcCtD
Acitretin—Asthenia—Epirubicin—liver cancer	0.000156	0.000687	CcSEcCtD
Acitretin—Pruritus—Epirubicin—liver cancer	0.000154	0.000678	CcSEcCtD
Acitretin—Diarrhoea—Epirubicin—liver cancer	0.000149	0.000655	CcSEcCtD
Acitretin—Hypersensitivity—Doxorubicin—liver cancer	0.000148	0.000653	CcSEcCtD
Acitretin—Asthenia—Doxorubicin—liver cancer	0.000144	0.000636	CcSEcCtD
Acitretin—Dizziness—Epirubicin—liver cancer	0.000144	0.000633	CcSEcCtD
Acitretin—Pruritus—Doxorubicin—liver cancer	0.000142	0.000627	CcSEcCtD
Acitretin—Vomiting—Epirubicin—liver cancer	0.000138	0.000609	CcSEcCtD
Acitretin—Diarrhoea—Doxorubicin—liver cancer	0.000138	0.000606	CcSEcCtD
Acitretin—Rash—Epirubicin—liver cancer	0.000137	0.000604	CcSEcCtD
Acitretin—Dermatitis—Epirubicin—liver cancer	0.000137	0.000603	CcSEcCtD
Acitretin—Headache—Epirubicin—liver cancer	0.000136	0.0006	CcSEcCtD
Acitretin—Dizziness—Doxorubicin—liver cancer	0.000133	0.000586	CcSEcCtD
Acitretin—Nausea—Epirubicin—liver cancer	0.000129	0.000569	CcSEcCtD
Acitretin—Vomiting—Doxorubicin—liver cancer	0.000128	0.000564	CcSEcCtD
Acitretin—Rash—Doxorubicin—liver cancer	0.000127	0.000559	CcSEcCtD
Acitretin—Dermatitis—Doxorubicin—liver cancer	0.000127	0.000558	CcSEcCtD
Acitretin—Headache—Doxorubicin—liver cancer	0.000126	0.000555	CcSEcCtD
Acitretin—Nausea—Doxorubicin—liver cancer	0.000119	0.000527	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	5.25e-05	0.000161	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	5.24e-05	0.00016	CbGpPWpGaD
Acitretin—ALB—Platelet degranulation—VEGFA—liver cancer	5.22e-05	0.00016	CbGpPWpGaD
Acitretin—RARB—Generic Transcription Pathway—MYC—liver cancer	5.22e-05	0.00016	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—TNF—liver cancer	5.22e-05	0.00016	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—HGF—liver cancer	5.21e-05	0.000159	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—PPARA—liver cancer	5.21e-05	0.000159	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GSTA4—liver cancer	5.2e-05	0.000159	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—ESR1—liver cancer	5.18e-05	0.000159	CbGpPWpGaD
Acitretin—ALB—Vitamin B12 Metabolism—IL6—liver cancer	5.18e-05	0.000158	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—CSF2—liver cancer	5.16e-05	0.000158	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—F2—liver cancer	5.12e-05	0.000157	CbGpPWpGaD
Acitretin—RARA—Gene Expression—PPARA—liver cancer	5.11e-05	0.000156	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—PPARA—liver cancer	5.11e-05	0.000156	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	5.09e-05	0.000156	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—HNF4A—liver cancer	5.07e-05	0.000155	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GSTA2—liver cancer	5.07e-05	0.000155	CbGpPWpGaD
Acitretin—RBP1—Disease—CDKN1B—liver cancer	5.03e-05	0.000154	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—MAPK14—liver cancer	5.02e-05	0.000154	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—ESR1—liver cancer	5.01e-05	0.000153	CbGpPWpGaD
Acitretin—RARA—Generic Transcription Pathway—MYC—liver cancer	5e-05	0.000153	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—MYC—liver cancer	5e-05	0.000153	CbGpPWpGaD
Acitretin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—liver cancer	4.97e-05	0.000152	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—ESR1—liver cancer	4.93e-05	0.000151	CbGpPWpGaD
Acitretin—RARB—Gene Expression—MAPK14—liver cancer	4.92e-05	0.000151	CbGpPWpGaD
Acitretin—RARG—Gene Expression—PPARG—liver cancer	4.91e-05	0.00015	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—APC—liver cancer	4.9e-05	0.00015	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PIK3CG—liver cancer	4.9e-05	0.00015	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GSTA1—liver cancer	4.89e-05	0.00015	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	4.89e-05	0.00015	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	4.85e-05	0.000148	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—KDR—liver cancer	4.84e-05	0.000148	CbGpPWpGaD
Acitretin—RXRA—Metabolism—NAT2—liver cancer	4.84e-05	0.000148	CbGpPWpGaD
Acitretin—RARB—Gene Expression—ESR1—liver cancer	4.83e-05	0.000148	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MAPK14—liver cancer	4.81e-05	0.000147	CbGpPWpGaD
Acitretin—ALB—Platelet degranulation—TGFB1—liver cancer	4.79e-05	0.000147	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PIK3CG—liver cancer	4.78e-05	0.000146	CbGpPWpGaD
Acitretin—RBP1—Disease—CTNNB1—liver cancer	4.75e-05	0.000145	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MET—liver cancer	4.74e-05	0.000145	CbGpPWpGaD
Acitretin—RARA—Gene Expression—MAPK14—liver cancer	4.72e-05	0.000144	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—MAPK14—liver cancer	4.72e-05	0.000144	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PPARA—liver cancer	4.65e-05	0.000142	CbGpPWpGaD
Acitretin—RBP1—Disease—CDKN1A—liver cancer	4.64e-05	0.000142	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ALDOB—liver cancer	4.64e-05	0.000142	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—ESR1—liver cancer	4.63e-05	0.000142	CbGpPWpGaD
Acitretin—RARA—Gene Expression—ESR1—liver cancer	4.63e-05	0.000142	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PPARG—liver cancer	4.61e-05	0.000141	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—BRAF—liver cancer	4.61e-05	0.000141	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—TP53—liver cancer	4.6e-05	0.000141	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—PPARG—liver cancer	4.57e-05	0.00014	CbGpPWpGaD
Acitretin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—liver cancer	4.56e-05	0.00014	CbGpPWpGaD
Acitretin—ALB—Hemostasis—SERPINA1—liver cancer	4.56e-05	0.000139	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	4.53e-05	0.000139	CbGpPWpGaD
Acitretin—ALB—Metabolism—UGDH—liver cancer	4.52e-05	0.000138	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—PPARG—liver cancer	4.49e-05	0.000137	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	4.46e-05	0.000136	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—PSMA4—liver cancer	4.43e-05	0.000136	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—PSMD10—liver cancer	4.43e-05	0.000136	CbGpPWpGaD
Acitretin—RARG—Gene Expression—SERPINE1—liver cancer	4.43e-05	0.000135	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CRABP1—liver cancer	4.42e-05	0.000135	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—PPARA—liver cancer	4.42e-05	0.000135	CbGpPWpGaD
Acitretin—RARB—Gene Expression—PPARG—liver cancer	4.41e-05	0.000135	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	4.31e-05	0.000132	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PIK3CD—liver cancer	4.31e-05	0.000132	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—PPARG—liver cancer	4.3e-05	0.000132	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—SERPINE1—liver cancer	4.26e-05	0.00013	CbGpPWpGaD
Acitretin—ALB—Metabolism—EPT1—liver cancer	4.25e-05	0.00013	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—PPARG—liver cancer	4.22e-05	0.000129	CbGpPWpGaD
Acitretin—RARA—Gene Expression—PPARG—liver cancer	4.22e-05	0.000129	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—IL6—liver cancer	4.21e-05	0.000129	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PIK3CD—liver cancer	4.2e-05	0.000128	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—MAPK14—liver cancer	4.18e-05	0.000128	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—ALB—liver cancer	4.15e-05	0.000127	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—TNF—liver cancer	4.15e-05	0.000127	CbGpPWpGaD
Acitretin—RBP1—Disease—STAT3—liver cancer	4.14e-05	0.000127	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—SERPINE1—liver cancer	4.12e-05	0.000126	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—SERPINE1—liver cancer	4.05e-05	0.000124	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—F2—liver cancer	4.05e-05	0.000124	CbGpPWpGaD
Acitretin—ALB—Metabolism—TAT—liver cancer	4.03e-05	0.000123	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.98e-05	0.000122	CbGpPWpGaD
Acitretin—RARB—Gene Expression—SERPINE1—liver cancer	3.97e-05	0.000121	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	3.96e-05	0.000121	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MMP2—liver cancer	3.95e-05	0.000121	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CG—liver cancer	3.87e-05	0.000118	CbGpPWpGaD
Acitretin—RXRA—Metabolism—HPGDS—liver cancer	3.87e-05	0.000118	CbGpPWpGaD
Acitretin—RBP1—Disease—MYC—liver cancer	3.85e-05	0.000118	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—RAF1—liver cancer	3.85e-05	0.000118	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.84e-05	0.000118	CbGpPWpGaD
Acitretin—RBP1—Disease—TGFB1—liver cancer	3.84e-05	0.000117	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—SERPINE1—liver cancer	3.81e-05	0.000116	CbGpPWpGaD
Acitretin—RARA—Gene Expression—SERPINE1—liver cancer	3.81e-05	0.000116	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PIK3CB—liver cancer	3.75e-05	0.000115	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MTOR—liver cancer	3.75e-05	0.000115	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PIK3CB—liver cancer	3.66e-05	0.000112	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	3.64e-05	0.000111	CbGpPWpGaD
Acitretin—RBP1—Disease—KRAS—liver cancer	3.56e-05	0.000109	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CDKN1B—liver cancer	3.52e-05	0.000108	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.5e-05	0.000107	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—RAF1—liver cancer	3.5e-05	0.000107	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.46e-05	0.000106	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CASP3—liver cancer	3.45e-05	0.000106	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—IL2—liver cancer	3.45e-05	0.000105	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PSMD10—liver cancer	3.45e-05	0.000105	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PSMA4—liver cancer	3.45e-05	0.000105	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CD—liver cancer	3.4e-05	0.000104	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IFNA1—liver cancer	3.4e-05	0.000104	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—SERPINE1—liver cancer	3.37e-05	0.000103	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CCND1—liver cancer	3.36e-05	0.000103	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—JUN—liver cancer	3.35e-05	0.000103	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GOT2—liver cancer	3.35e-05	0.000103	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—IL6—liver cancer	3.35e-05	0.000102	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CTNNB1—liver cancer	3.33e-05	0.000102	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—ALB—liver cancer	3.29e-05	0.000101	CbGpPWpGaD
Acitretin—RBP1—Disease—PIK3CA—liver cancer	3.27e-05	0.0001	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MMP9—liver cancer	3.26e-05	9.98e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CDKN1A—liver cancer	3.25e-05	9.94e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MAPK8—liver cancer	3.17e-05	9.71e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CYP2E1—liver cancer	3.15e-05	9.64e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.05e-05	9.33e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—RAF1—liver cancer	3.04e-05	9.29e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—CTNNB1—liver cancer	3.03e-05	9.27e-05	CbGpPWpGaD
Acitretin—RBP1—Disease—HRAS—liver cancer	3.02e-05	9.25e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PRKCE—liver cancer	3e-05	9.19e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—H2AFX—liver cancer	2.99e-05	9.16e-05	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—RAF1—liver cancer	2.97e-05	9.09e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MMP9—liver cancer	2.97e-05	9.08e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CB—liver cancer	2.97e-05	9.07e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—GGT1—liver cancer	2.96e-05	9.07e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CYCS—liver cancer	2.95e-05	9.02e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—VEGFA—liver cancer	2.93e-05	8.96e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—STAT3—liver cancer	2.9e-05	8.87e-05	CbGpPWpGaD
Acitretin—RBP1—Disease—IL6—liver cancer	2.89e-05	8.85e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GGT1—liver cancer	2.89e-05	8.85e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GOT1—liver cancer	2.89e-05	8.85e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—CYCS—liver cancer	2.87e-05	8.78e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—ABL1—liver cancer	2.86e-05	8.74e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IGF2—liver cancer	2.85e-05	8.7e-05	CbGpPWpGaD
Acitretin—RARG—Gene Expression—MYC—liver cancer	2.8e-05	8.57e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CPT1B—liver cancer	2.74e-05	8.37e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GLUL—liver cancer	2.74e-05	8.37e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—IL2—liver cancer	2.72e-05	8.33e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MYC—liver cancer	2.7e-05	8.25e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TGFB1—liver cancer	2.69e-05	8.23e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—HGF—liver cancer	2.69e-05	8.22e-05	CbGpPWpGaD
Acitretin—RBP1—Disease—AKT1—liver cancer	2.67e-05	8.17e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—VEGFA—liver cancer	2.67e-05	8.16e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—PPARA—liver cancer	2.66e-05	8.15e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—CSF2—liver cancer	2.66e-05	8.13e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—STAT3—liver cancer	2.64e-05	8.08e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—NR1H4—liver cancer	2.64e-05	8.07e-05	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—MYC—liver cancer	2.61e-05	7.97e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GSTP1—liver cancer	2.6e-05	7.95e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTA3—liver cancer	2.59e-05	7.94e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—HMOX1—liver cancer	2.56e-05	7.84e-05	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—MYC—liver cancer	2.56e-05	7.84e-05	CbGpPWpGaD
Acitretin—RARB—Gene Expression—MYC—liver cancer	2.51e-05	7.68e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—HMOX1—liver cancer	2.5e-05	7.64e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—KRAS—liver cancer	2.49e-05	7.62e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—MAPK14—liver cancer	2.46e-05	7.52e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—TGFB1—liver cancer	2.45e-05	7.49e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—ESR1—liver cancer	2.41e-05	7.38e-05	CbGpPWpGaD
Acitretin—RARA—Gene Expression—MYC—liver cancer	2.41e-05	7.37e-05	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—MYC—liver cancer	2.41e-05	7.37e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GSTM1—liver cancer	2.39e-05	7.31e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTA4—liver cancer	2.37e-05	7.26e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.32e-05	7.09e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—VEGFA—liver cancer	2.32e-05	7.08e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTA2—liver cancer	2.31e-05	7.07e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PIK3CA—liver cancer	2.29e-05	7e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—TNF—liver cancer	2.29e-05	6.99e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—KRAS—liver cancer	2.27e-05	6.94e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CYP1A1—liver cancer	2.26e-05	6.93e-05	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PIK3CA—liver cancer	2.23e-05	6.82e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTA1—liver cancer	2.23e-05	6.82e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TP53—liver cancer	2.21e-05	6.77e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—NAT2—liver cancer	2.21e-05	6.75e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—PPARG—liver cancer	2.2e-05	6.73e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—MAPK14—liver cancer	2.15e-05	6.58e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—TGFB1—liver cancer	2.13e-05	6.5e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.12e-05	6.49e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—HRAS—liver cancer	2.12e-05	6.48e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ALDOB—liver cancer	2.12e-05	6.47e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—MTHFR—liver cancer	2.11e-05	6.46e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—F2—liver cancer	2.09e-05	6.38e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PPARA—liver cancer	2.07e-05	6.33e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—IL6—liver cancer	2.03e-05	6.2e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CRABP1—liver cancer	2.02e-05	6.17e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—PPARA—liver cancer	2.02e-05	6.17e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CG—liver cancer	2e-05	6.1e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—SERPINE1—liver cancer	1.98e-05	6.07e-05	CbGpPWpGaD
Acitretin—RARG—Gene Expression—AKT1—liver cancer	1.94e-05	5.94e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—HRAS—liver cancer	1.93e-05	5.89e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—AKT1—liver cancer	1.87e-05	5.72e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.86e-05	5.69e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—IL6—liver cancer	1.84e-05	5.64e-05	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—AKT1—liver cancer	1.82e-05	5.57e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.82e-05	5.56e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	1.81e-05	5.53e-05	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—AKT1—liver cancer	1.78e-05	5.43e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CG—liver cancer	1.77e-05	5.43e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—HPGDS—liver cancer	1.76e-05	5.39e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CD—liver cancer	1.75e-05	5.37e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.75e-05	5.36e-05	CbGpPWpGaD
Acitretin—RARB—Gene Expression—AKT1—liver cancer	1.74e-05	5.33e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—SERPINE1—liver cancer	1.74e-05	5.31e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PPARG—liver cancer	1.71e-05	5.24e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—AKT1—liver cancer	1.7e-05	5.21e-05	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—AKT1—liver cancer	1.67e-05	5.11e-05	CbGpPWpGaD
Acitretin—RARA—Gene Expression—AKT1—liver cancer	1.67e-05	5.11e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.6e-05	4.88e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PSMD10—liver cancer	1.57e-05	4.81e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PSMA4—liver cancer	1.57e-05	4.81e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—RAF1—liver cancer	1.57e-05	4.79e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CD—liver cancer	1.56e-05	4.77e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ALB—liver cancer	1.54e-05	4.71e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GOT2—liver cancer	1.53e-05	4.68e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CB—liver cancer	1.53e-05	4.68e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—AKT1—liver cancer	1.48e-05	4.52e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP2E1—liver cancer	1.44e-05	4.4e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IL2—liver cancer	1.4e-05	4.29e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.39e-05	4.26e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CB—liver cancer	1.36e-05	4.16e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—RAF1—liver cancer	1.36e-05	4.15e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYCS—liver cancer	1.35e-05	4.11e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GGT1—liver cancer	1.32e-05	4.04e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GOT1—liver cancer	1.32e-05	4.04e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—MYC—liver cancer	1.26e-05	3.84e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—VEGFA—liver cancer	1.19e-05	3.65e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTP1—liver cancer	1.19e-05	3.63e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—HMOX1—liver cancer	1.17e-05	3.58e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TGFB1—liver cancer	1.1e-05	3.35e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTM1—liver cancer	1.09e-05	3.33e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP1A1—liver cancer	1.03e-05	3.16e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—KRAS—liver cancer	1.01e-05	3.1e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—MTHFR—liver cancer	9.63e-06	2.95e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PPARA—liver cancer	9.45e-06	2.89e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CA—liver cancer	9.32e-06	2.85e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TP53—liver cancer	9.02e-06	2.76e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—AKT1—liver cancer	8.71e-06	2.66e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—HRAS—liver cancer	8.62e-06	2.64e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.49e-06	2.6e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CA—liver cancer	8.29e-06	2.53e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CG—liver cancer	8.09e-06	2.47e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PPARG—liver cancer	7.81e-06	2.39e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—AKT1—liver cancer	7.62e-06	2.33e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CD—liver cancer	7.11e-06	2.18e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—AKT1—liver cancer	6.77e-06	2.07e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CB—liver cancer	6.2e-06	1.9e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CA—liver cancer	3.78e-06	1.16e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—AKT1—liver cancer	3.09e-06	9.44e-06	CbGpPWpGaD
